Can Wegovy Cause Sleeplessness or Disturbed Sleep?

What clinical trials and the SmPC tell us about semaglutide sleeplessness

The STEP 1 trial, published in the New England Journal of Medicine, followed 1,961 adults using semaglutide 2.4mg over 68 weeks. Sleep disturbance was not identified as a statistically notable adverse event in that dataset. The UK Summary of Product Characteristics for Wegovy, which reflects the totality of trial data submitted to regulators, does not list insomnia or sleeplessness among common reactions (those occurring in more than one in a hundred people).

That might sound reassuring, and for most people it is. The misconception worth setting aside gently is that because sleeplessness is not on the formal list, anyone experiencing it must be imagining a connection. Post-marketing experience and clinical observation tell a more nuanced story: indirect effects, particularly upper gastrointestinal symptoms, are common and well-documented, and disturbed sleep is a natural downstream consequence of lying down with reflux or nausea.

The NHS semaglutide medicines page confirms that nausea, heartburn, burping and reflux are common reactions, especially after starting treatment or moving up a dose. Those symptoms peak in the evening for some people, making the hours around bedtime uncomfortable enough to fragment sleep without semaglutide itself touching a single sleep-regulating pathway.

Why Wegovy can disrupt sleep even when the drug isn't acting on the brain

Semaglutide slows gastric emptying. Food that would ordinarily clear the stomach in a few hours stays there longer. If your evening meal is large or high in fat, the stomach is still working when you lie down, and the combination of delayed emptying and a horizontal position raises the risk of acid travelling upward. The result can be heartburn, a sour taste, or simply an uncomfortable fullness that keeps you awake. This is a well-understood mechanism, not speculation.

There is also a fatigue angle worth noting. Many people feel notably tired, particularly after a dose increase, and if you are curious whether that tiredness is a recognised pattern, our page on whether Wegovy causes sleepiness walks through what the evidence shows. Some people also report vivid dreams in the early weeks of treatment, though this sits firmly in the anecdotal category rather than the trial-evidence one.

Separately, if you are losing weight quickly through reduced calorie intake, sleep architecture can shift during periods of significant energy restriction. This is not specific to Wegovy; it applies to substantial calorie deficits generally. Protein adequacy and hydration both support better sleep quality alongside any weight-loss programme, which is worth raising with your prescriber or a dietitian. For a closer look at how the medication interacts with rest more broadly, our guide on Wegovy and sleep brings together what the evidence and clinical experience suggest.

If sleep difficulties are affecting you, the broader picture of how Wegovy can cause sleep problems covers what practical adjustments tend to help, alongside a fuller look at the indirect mechanisms involved.

What practical steps tend to help, and when to speak to your prescriber

Timing matters. Giving your weekly injection in the morning rather than the evening means peak plasma levels and any accompanying nausea are largely worked through before bed. Keeping your evening meal lighter and earlier, and avoiding lying flat for at least two hours after eating, reduces the chance of reflux-driven wakefulness. These are adjustments most people can make without clinical guidance, though your prescriber may have specific suggestions based on your health history.

Persistent sleeplessness is a different matter. If you are still waking repeatedly after three or four weeks on a stable dose, or if difficulty sleeping is accompanied by low mood, anxiety or other changes in how you feel, those are conversations to have with your prescriber rather than things to manage quietly. You can also explore whether mood-related side effects are part of the picture.

It is also worth knowing that Wegovy sits under additional MHRA monitoring as a Black Triangle (▼) medicine, which means any suspected side effects, including sleep disturbances you are uncertain about, can be reported at the Yellow Card scheme. You do not need to be certain of a causal link to report; the whole point of post-marketing surveillance is to build exactly that picture over time.

If you are weighing up the broader side-effect profile before starting, the semaglutide overview sets out what the clinical data show across the most common reactions. And if cost is part of your thinking, the Wegovy cost guide explains what a legitimate private prescription actually includes. When you are ready to talk through your suitability with a clinician, speak to our prescribers through a free consultation.